Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Jan 15;369(Pt 2):255–262. doi: 10.1042/BJ20020694

Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.

Martin Hersberger 1, Susannah Patarroyo-White 1, Xiaobing Qian 1, Kay S Arnold 1, Lucia Rohrer 1, Maureen E Balestra 1, Thomas L Innerarity 1
PMCID: PMC1223090  PMID: 12374571

Abstract

Apolipoprotein (apo) B mRNA editing is the deamination of C(6666) to uridine, which results in translation of the apoB-48 protein instead of the genomically encoded apoB-100. ApoB-48-containing lipoproteins are cleared more rapidly from plasma and are less atherogenic than apoB-100-containing low-density lipoproteins (LDLs). In humans, the intestine predominantly produces apoB-48 whereas the liver secretes apoB-100 only. To evaluate a potential therapeutic use for liver-induced apoB mRNA editing in humans, we investigated the efficiency and safety of transgenic expression of apoB mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in the absence of endogenous editing in the mouse model. Here we show that regulatable tetO-mediated APOBEC-1 expression in the livers of gene-targeted mice lacking endogenous APOBEC-1 results in 30% apoB mRNA editing. In a time-course experiment, the expression of tetO-APOBEC-1 mRNA was suppressed within 2 days after mice were fed doxycycline and apoB mRNA editing and apoB-48 formation were suppressed within 4 days. However, tetO-APOBEC-1 expression resulted in regulatable aberrant hyperediting of several cytidines downstream of C(6666) in apoB mRNA and in novel APOBEC-1 target 1 (NAT1) mRNA. Several of the cytidines in apoB mRNA were hyperedited to a level similar to that of C(6666), although editing at C(6666) was lower than that in wild-type mice. These results demonstrate that even moderate APOBEC-1 expression can lead to hyperediting, limiting the single-gene approach for gene therapy with APOBEC-1.

Full Text

The Full Text of this article is available as a PDF (243.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum C. L., Teng B. B., Davidson N. O. Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J Biol Chem. 1990 Nov 5;265(31):19263–19270. [PubMed] [Google Scholar]
  2. Boren J., Lee I., Zhu W., Arnold K., Taylor S., Innerarity T. L. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J Clin Invest. 1998 Mar 1;101(5):1084–1093. doi: 10.1172/JCI1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boström K., Garcia Z., Poksay K. S., Johnson D. F., Lusis A. J., Innerarity T. L. Apolipoprotein B mRNA editing. Direct determination of the edited base and occurrence in non-apolipoprotein B-producing cell lines. J Biol Chem. 1990 Dec 25;265(36):22446–22452. [PubMed] [Google Scholar]
  4. Breen K., Schenker S., Heimberg M. The effect of tetracycline on the hepatic secretion of triglyceride. Biochim Biophys Acta. 1972 May 23;270(1):74–80. doi: 10.1016/0005-2760(72)90179-8. [DOI] [PubMed] [Google Scholar]
  5. Böcker R., Estler C. J., Maywald M., Weber D. Comparative evaluation of the effects of tetracycline and doxycycline on blood and liver lipids on male and female mice. Arzneimittelforschung. 1981;31(12):2118–2120. [PubMed] [Google Scholar]
  6. Chan L., Chang B. H., Nakamuta M., Li W. H., Smith L. C. Apobec-1 and apolipoprotein B mRNA editing. Biochim Biophys Acta. 1997 Mar 10;1345(1):11–26. doi: 10.1016/s0005-2760(96)00156-7. [DOI] [PubMed] [Google Scholar]
  7. Chen S. H., Habib G., Yang C. Y., Gu Z. W., Lee B. R., Weng S. A., Silberman S. R., Cai S. J., Deslypere J. P., Rosseneu M. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science. 1987 Oct 16;238(4825):363–366. doi: 10.1126/science.3659919. [DOI] [PubMed] [Google Scholar]
  8. Davidson N. O., Carlos R. C., Drewek M. J., Parmer T. G. Apolipoprotein gene expression in the rat is regulated in a tissue-specific manner by thyroid hormone. J Lipid Res. 1988 Nov;29(11):1511–1522. [PubMed] [Google Scholar]
  9. Davidson N. O., Innerarity T. L., Scott J., Smith H., Driscoll D. M., Teng B., Chan L. Proposed nomenclature for the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme: APOBEC-1. RNA. 1995 Mar;1(1):3–3. [PMC free article] [PubMed] [Google Scholar]
  10. Estler C. J., Böcker R. Role of sex and age in the tetracycline-induced hepatic steatosis. I. Comparative study on the effect of rolitetracycline on some parameters of hepatic lipid metabolism in male and female mice. Toxicol Appl Pharmacol. 1980 Jul;54(3):508–513. doi: 10.1016/0041-008x(80)90178-7. [DOI] [PubMed] [Google Scholar]
  11. Fan J., Wang J., Bensadoun A., Lauer S. J., Dang Q., Mahley R. W., Taylor J. M. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8724–8728. doi: 10.1073/pnas.91.18.8724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Farese R. V., Jr, Cases S., Ruland S. L., Kayden H. J., Wong J. S., Young S. G., Hamilton R. L. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J Lipid Res. 1996 Feb;37(2):347–360. [PubMed] [Google Scholar]
  13. Glickman R. M., Rogers M., Glickman J. N. Apolipoprotein B synthesis by human liver and intestine in vitro. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5296–5300. doi: 10.1073/pnas.83.14.5296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5547–5551. doi: 10.1073/pnas.89.12.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gossen M., Freundlieb S., Bender G., Müller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995 Jun 23;268(5218):1766–1769. doi: 10.1126/science.7792603. [DOI] [PubMed] [Google Scholar]
  16. Greeve J., Lellek H., Rautenberg P., Greten H. Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes. Biol Chem. 1998 Aug-Sep;379(8-9):1063–1073. doi: 10.1515/bchm.1998.379.8-9.1063. [DOI] [PubMed] [Google Scholar]
  17. Harris S. G., Smith H. C. In vitro apolipoprotein B mRNA editing activity can be modulated by fasting and refeeding rats with a high carbohydrate diet. Biochem Biophys Res Commun. 1992 Mar 16;183(2):899–903. doi: 10.1016/0006-291x(92)90568-6. [DOI] [PubMed] [Google Scholar]
  18. Hersberger M., Innerarity T. L. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J Biol Chem. 1998 Apr 17;273(16):9435–9442. doi: 10.1074/jbc.273.16.9435. [DOI] [PubMed] [Google Scholar]
  19. Hersberger M., Kirby K., Phillips J. P., Würgler F. E., Koller T., Widmer R. M. A plasmid rescue to investigate mutagenesis in transgenic D. melanogaster. Mutat Res. 1996 Dec 12;361(2-3):165–172. doi: 10.1016/s0165-1161(96)90251-4. [DOI] [PubMed] [Google Scholar]
  20. Hersberger M., Patarroyo-White S., Arnold K. S., Innerarity T. L. Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3' efficiency element. J Biol Chem. 1999 Dec 3;274(49):34590–34597. doi: 10.1074/jbc.274.49.34590. [DOI] [PubMed] [Google Scholar]
  21. Hirano K., Young S. G., Farese R. V., Jr, Ng J., Sande E., Warburton C., Powell-Braxton L. M., Davidson N. O. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem. 1996 Apr 26;271(17):9887–9890. doi: 10.1074/jbc.271.17.9887. [DOI] [PubMed] [Google Scholar]
  22. Hodges P. E., Navaratnam N., Greeve J. C., Scott J. Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing. Nucleic Acids Res. 1991 Mar 25;19(6):1197–1201. doi: 10.1093/nar/19.6.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Horie Y., Fazio S., Westerlund J. R., Weisgraber K. H., Rall S. C., Jr The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J Biol Chem. 1992 Jan 25;267(3):1962–1968. [PubMed] [Google Scholar]
  24. Hughes S. D., Rouy D., Navaratnam N., Scott J., Rubin E. M. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits. Hum Gene Ther. 1996 Jan;7(1):39–49. doi: 10.1089/hum.1996.7.1-39. [DOI] [PubMed] [Google Scholar]
  25. Innerarity T. L., Borén J., Yamanaka S., Olofsson S. O. Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J Biol Chem. 1996 Feb 2;271(5):2353–2356. doi: 10.1074/jbc.271.5.2353. [DOI] [PubMed] [Google Scholar]
  26. Innerarity T. L., Mahley R. W. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry. 1978 Apr 18;17(8):1440–1447. doi: 10.1021/bi00601a013. [DOI] [PubMed] [Google Scholar]
  27. Johnson D. F., Poksay K. S., Innerarity T. L. The mechanism for apo-B mRNA editing is deamination. Biochem Biophys Res Commun. 1993 Sep 30;195(3):1204–1210. doi: 10.1006/bbrc.1993.2172. [DOI] [PubMed] [Google Scholar]
  28. Kistner A., Gossen M., Zimmermann F., Jerecic J., Ullmer C., Lübbert H., Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10933–10938. doi: 10.1073/pnas.93.20.10933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kozarsky K. F., Bonen D. K., Giannoni F., Funahashi T., Wilson J. M., Davidson N. O. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther. 1996 May 20;7(8):943–957. doi: 10.1089/hum.1996.7.8-943. [DOI] [PubMed] [Google Scholar]
  30. Lau P. P., Cahill D. J., Zhu H. J., Chan L. Ethanol modulates apolipoprotein B mRNA editing in the rat. J Lipid Res. 1995 Oct;36(10):2069–2078. [PubMed] [Google Scholar]
  31. Lau P. P., Xiong W. J., Zhu H. J., Chen S. H., Chan L. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J Biol Chem. 1991 Oct 25;266(30):20550–20554. [PubMed] [Google Scholar]
  32. Lau P. P., Zhu H. J., Nakamuta M., Chan L. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J Biol Chem. 1997 Jan 17;272(3):1452–1455. doi: 10.1074/jbc.272.3.1452. [DOI] [PubMed] [Google Scholar]
  33. Leighton J. K., Joyner J., Zamarripa J., Deines M., Davis R. A. Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. J Lipid Res. 1990 Sep;31(9):1663–1668. [PubMed] [Google Scholar]
  34. Lellek H., Kirsten R., Diehl I., Apostel F., Buck F., Greeve J. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem. 2000 Jun 30;275(26):19848–19856. doi: 10.1074/jbc.M001786200. [DOI] [PubMed] [Google Scholar]
  35. Mehta A., Kinter M. T., Sherman N. E., Driscoll D. M. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol. 2000 Mar;20(5):1846–1854. doi: 10.1128/mcb.20.5.1846-1854.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Navaratnam N., Morrison J. R., Bhattacharya S., Patel D., Funahashi T., Giannoni F., Teng B. B., Davidson N. O., Scott J. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem. 1993 Oct 5;268(28):20709–20712. [PubMed] [Google Scholar]
  37. Navaratnam N., Shah R., Patel D., Fay V., Scott J. Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):222–226. doi: 10.1073/pnas.90.1.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pitas R. E., Innerarity T. L., Mahley R. W. Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J Biol Chem. 1980 Jun 10;255(11):5454–5460. [PubMed] [Google Scholar]
  39. Powell L. M., Wallis S. C., Pease R. J., Edwards Y. H., Knott T. J., Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell. 1987 Sep 11;50(6):831–840. doi: 10.1016/0092-8674(87)90510-1. [DOI] [PubMed] [Google Scholar]
  40. Qian X., Balestra M. E., Yamanaka S., Borén J., Lee I., Innerarity T. L. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Arterioscler Thromb Vasc Biol. 1998 Jun;18(6):1013–1020. doi: 10.1161/01.atv.18.6.1013. [DOI] [PubMed] [Google Scholar]
  41. Richardson N., Navaratnam N., Scott J. Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop. J Biol Chem. 1998 Nov 27;273(48):31707–31717. doi: 10.1074/jbc.273.48.31707. [DOI] [PubMed] [Google Scholar]
  42. Schock D., Kuo S. R., Steinburg M. F., Bolognino M., Sparks J. D., Sparks C. E., Smith H. C. An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1097–1102. doi: 10.1073/pnas.93.3.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Siddiqui J. F., Van Mater D., Sowden M. P., Smith H. C. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity. Exp Cell Res. 1999 Oct 10;252(1):154–164. doi: 10.1006/excr.1999.4598. [DOI] [PubMed] [Google Scholar]
  44. Sowden M. P., Eagleton M. J., Smith H. C. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing. Nucleic Acids Res. 1998 Apr 1;26(7):1644–1652. doi: 10.1093/nar/26.7.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sowden M., Hamm J. K., Smith H. C. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J Biol Chem. 1996 Feb 9;271(6):3011–3017. doi: 10.1074/jbc.271.6.3011. [DOI] [PubMed] [Google Scholar]
  46. Teng B., Blumenthal S., Forte T., Navaratnam N., Scott J., Gotto A. M., Jr, Chan L. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem. 1994 Nov 25;269(47):29395–29404. [PubMed] [Google Scholar]
  47. Teng B., Burant C. F., Davidson N. O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 1993 Jun 18;260(5115):1816–1819. doi: 10.1126/science.8511591. [DOI] [PubMed] [Google Scholar]
  48. Teng B., Ishida B., Forte T. M., Blumenthal S., Song L. Z., Gotto A. M., Jr, Chan L. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1). Arterioscler Thromb Vasc Biol. 1997 May;17(5):889–897. doi: 10.1161/01.atv.17.5.889. [DOI] [PubMed] [Google Scholar]
  49. Véniant M. M., Zlot C. H., Walzem R. L., Pierotti V., Driscoll R., Dichek D., Herz J., Young S. G. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. J Clin Invest. 1998 Oct 15;102(8):1559–1568. doi: 10.1172/JCI4164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yamanaka S., Balestra M. E., Ferrell L. D., Fan J., Arnold K. S., Taylor S., Taylor J. M., Innerarity T. L. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8483–8487. doi: 10.1073/pnas.92.18.8483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yamanaka S., Poksay K. S., Arnold K. S., Innerarity T. L. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 1997 Feb 1;11(3):321–333. doi: 10.1101/gad.11.3.321. [DOI] [PubMed] [Google Scholar]
  52. Yamanaka S., Poksay K. S., Balestra M. E., Zeng G. Q., Innerarity T. L. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J Biol Chem. 1994 Aug 26;269(34):21725–21734. [PubMed] [Google Scholar]
  53. Yamanaka S., Poksay K. S., Driscoll D. M., Innerarity T. L. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem. 1996 May 10;271(19):11506–11510. doi: 10.1074/jbc.271.19.11506. [DOI] [PubMed] [Google Scholar]
  54. Yang Y., Sowden M. P., Smith H. C. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1. J Biol Chem. 2000 Jul 28;275(30):22663–22669. doi: 10.1074/jbc.M910406199. [DOI] [PubMed] [Google Scholar]
  55. Yang Y., Yang Y., Kovalski K., Smith H. C. Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through APOBEC-1 affinity chromatography. J Biol Chem. 1997 Oct 31;272(44):27700–27706. doi: 10.1074/jbc.272.44.27700. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES